| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8537707 | Pulmonary Pharmacology & Therapeutics | 2018 | 33 Pages |
Abstract
Overall, we recommend EAP as the optimal choice for patients with PAH in clinical practice and PAE as suboptimal in view of their desirable performance in efficacy. Most of the combination therapies performed better than monotherapies.
Related Topics
Health Sciences
Medicine and Dentistry
Pulmonary and Respiratory Medicine
Authors
Hongjing Lin, Mupeng Wang, Ying Yu, Zeyu Qin, Xin Zhong, Jiahui Ma, Fangbo Zhao, Xueli Zhang,